425 related articles for article (PubMed ID: 3160786)
1. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
Liew FY; Singleton A; Cillari E; Howard JG
J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
Liew FY; Hodson K; Lelchuk R
J Immunol; 1987 Nov; 139(9):3112-7. PubMed ID: 3312413
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
Liew FY; Hale C; Howard JG
J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
[TBL] [Abstract][Full Text] [Related]
7. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
Liew FY; Hale C; Howard JG
J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
[TBL] [Abstract][Full Text] [Related]
8. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
Howard JG; Liew FY; Hale C; Nicklin S
J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
[TBL] [Abstract][Full Text] [Related]
10. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
[TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
13. A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.
Farrell JP; Muller I; Louis JA
J Immunol; 1989 Mar; 142(6):2052-6. PubMed ID: 2784148
[TBL] [Abstract][Full Text] [Related]
14. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
15. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
Moll H; Scollay R
Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
Chou T; Shu S
J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
[TBL] [Abstract][Full Text] [Related]
17. Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.
Lemire JM; Weigle WO
J Immunol; 1986 Nov; 137(10):3169-74. PubMed ID: 2430015
[TBL] [Abstract][Full Text] [Related]
18. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
Sacks DL; Scott PA; Asofsky R; Sher FA
J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
[TBL] [Abstract][Full Text] [Related]
20. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
Suzuki Y; Remington JS
J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]